Literature DB >> 8466245

Unusual cyclosporin related neurological complications in recipients of liver transplants.

M R Cilio1, O Danhaive, J F Gadisseux, J B Otte, E M Sokal.   

Abstract

In a series of 256 recipients of paediatric liver transplants, from 1984 to 1990, four patients presented with sudden onset seizures not explained by conventional work-up. None had a family or personal history of seizures. Infectious causes were excluded. There were no glucose or electrolyte disturbances. Seizures were not induced by systemic or intracranial hypertension. One child out of four had transient white matter and cortex focal lesions on computed tomography of the brain. One to 10 days before seizures all four children presented with supratherapeutic concentrations of serum cyclosporin that were determined by a non-specific method that measured the parent compound plus its metabolites. The supratherapeutic concentrations were not found with the specific method measuring cyclosporin alone. It is concluded that these seizures may correspond to a toxic effect of cyclosporin, probably due to one or several metabolites, as suggested by the discrepancy between specific and non-specific methods of determination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466245      PMCID: PMC1793864          DOI: 10.1136/adc.68.3.405

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  Early changes in the permeability of the blood-brain barrier produced by toxins associated with liver failure.

Authors:  H J McClung; H R Sloan; P Powers; A J Merola; R Murray; B Kerzner; J D Pollack
Journal:  Pediatr Res       Date:  1990-09       Impact factor: 3.756

2.  Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantation.

Authors:  P C de Groen; R H Wiesner; R A Krom
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

3.  Acute adenovirus hepatitis in liver transplant recipients.

Authors:  B Cames; J Rahier; G Burtomboy; J de Ville de Goyet; R Reding; M Lamy; J B Otte; E M Sokal
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

4.  Cyclosporine central neurotoxicity following renal transplantation. Report of a case using magnetic resonance images.

Authors:  S J Scheinman; E R Reinitz; G Petro; R A Schwartz; F S Szmalc
Journal:  Transplantation       Date:  1990-01       Impact factor: 4.939

5.  Hypertension and convulsions in children receiving cyclosporin A.

Authors:  D V Joss; A J Barrett; J R Kendra; C F Lucas; S Desai
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

6.  Liver transplantation in children less than 1 year of age.

Authors:  E M Sokal; F Veyckemans; J de Ville de Goyet; D Moulin; N Van Hoorebeeck; D Alberti; J P Buts; J Rahier; L Van Obbergh; P Clapuyt
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

7.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

8.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

9.  Central nervous system toxicity of cyclosporine in a rat model.

Authors:  L Famiglio; L Racusen; B Fivush; K Solez; R Fisher
Journal:  Transplantation       Date:  1989-08       Impact factor: 4.939

10.  Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation.

Authors:  J B Otte; J de Ville de Goyet; E Sokal; D Alberti; D Moulin; B de Hemptinne; F Veyckemans; L van Obbergh; M Carlier; P Clapuyt
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

View more
  3 in total

Review 1.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Quality of life after orthotopic liver transplantation in children. An overview of physical, psychological and social outcome.

Authors:  E M Sokal
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

3.  Posterior reversible encephalopathy syndrome after solid organ transplantation.

Authors:  W S Bartynski; H P Tan; J F Boardman; R Shapiro; J W Marsh
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.